Ciara Helland
YOU?
Author Swipe
View article: Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma Open
Summary Broad-spectrum RAS inhibition holds the potential to benefit roughly a quarter of human cancer patients whose tumors are driven by RAS mutations. However, the impact of inhibiting RAS functions in normal tissues is not known. RMC-7…